PHOENIX, Jan. 23,
2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:
SNES) today announced that Joel
Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will
participate in a fireside chat and host one-on-one meetings with
investors at the Lytham Partners 2024 Investor Select Conference,
taking place virtually on February 1,
2024.
Company Webcast
The webcasted fireside chat will take place at 2:45pm ET on
Thursday, February 1, 2024. The
webcast can be accessed at
https://wsw.com/webcast/lytham10/snes/2108880 or on the
Company's website at https://senestech.investorroom.com/. The
webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register
for the event at https://lythampartners.com/select2024invreg/.
Further information on the conference is available at
https://lythampartners.com/select2024.
About SenesTech
We are committed to improving the health of the world by
humanely managing animal pest populations through fertility
control. We are experts in fertility control to manage animal pest
populations. We invented ContraPest, the only U.S. EPA-registered
contraceptive for male and female rats, and Evolve, an
EPA-designated minimum-risk contraceptive currently offered for
rats. ContraPest and Evolve fit seamlessly into all integrated pest
management programs, significantly improving the overall goal of
effective pest management. We strive for clean cities, efficient
businesses and happy households – with a product designed to be
humane, effective and sustainable.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement The foregoing paragraphs
contain forward-looking statements that involve estimates,
assumptions, risks and uncertainties. Any statements about our
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and may be
forward-looking. "Forward-looking statements" may be preceded by
words such as "may," "future," "plan" or "planned," "will,"
"should," "expected," "anticipates," "continue," "eventually,"
"believes," or "projected." Forward-looking statements include
statements concerning the potential impact and effects of the
COVID-19 pandemic on the Company's business, results of operations
and financial performance; any measures the Company has and may
take in response to COVID-19 and any expectations the Company may
have with respect thereto; the Company's strategy and target
marketing and markets; continuing the Company's vision; expected
benefits of the Company's initiatives and continuation of those
initiatives; deployment of the Company's product; the continuation
or expansion of the use of ContraPest; demand for ContraPest; the
Company's expectation regarding costs, expenses and cash and
continuing its cost improvement plan; future financial results; and
the Company's execution of its strategic business plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-a-fireside-chat-at-the-lytham-partners-2024-investor-select-conference-on-february-1-2024-302041113.html
SOURCE SenesTech, Inc.